Position in NVO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$65,869
+$12,913 QoQ
Shares Held
1,374
-4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,105
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingdom Financial Group LLC. holds $1,463,105 across 13 Drug Manufacturers - General names. NVO ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,821 | $458,236 | |
| 2 | AMGN |
Amgen Inc
|
879 | $318,303 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,247 | $283,885 | |
| 4 | JNJ |
Johnson & Johnson
|
1,027 | $260,827 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
1,374 | $65,869 | |
| 6 | MRK |
Merck & Co., Inc.
|
211 | $27,113 | |
| 7 | LLY |
ELI LILLY & Co
|
22 | $26,387 | |
| 8 | PFE |
Pfizer Inc
|
587 | $14,134 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,869 | 1,374 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $52,956 | 1,441 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $40,754 | 801 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||